Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
HRT in Trouble
San Francisco - Despite the unexpected finding that combined use of oral conjugated equine estrogens (CEE) and oral medroxyprogesterone acetate (MPA) actually raises a healthy menopausal women's risk of coronary heart disease, and that it increases invasive breast cancer risk, gynecologist Susan Ballagh, M.D., remains a proponent of the popular regimen for appropriate patients.
Related Videos
Related Content
